Core Wealth Advisors, Inc. Pfizer Inc Transaction History

Core Wealth Advisors, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $18,291 - $23,758	-700 Reduced 65.42%	370 $10,000
Q3 2023 Nov 13, 2023	SELL	$32.09 - $37.51 $6,321 - $7,389	-197 Reduced 15.55%	1,070 $35,000
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $3,648 - $4,220	-101 Reduced 7.38%	1,267 $46,000
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $3,674 - $4,796	88 Added 6.88%	1,368 $70,000
Q3 2022 Nov 10, 2022	BUY	$43.76 - $53.42 $6,782 - $8,280	155 Added 13.78%	1,280 $56,000
Q1 2021 May 04, 2021	SELL	$33.49 - $37.77 $3,349 - $3,777	-100 Reduced 8.16%	1,125 $41,000
Q4 2020 Feb 05, 2021	SELL	$33.47 - $42.56 $10,241 - $13,023	-306 Reduced 19.99%	1,225 $45,000
Q3 2020 Nov 12, 2020	BUY	$31.75 - $37.25 $31 - $37	1 Added 0.07%	1,531 $56,000
Q2 2020 Jul 31, 2020	SELL	$30.12 - $36.54 $3,885 - $4,713	-129 Reduced 7.78%	1,530 $50,000
Q1 2020 Apr 29, 2020	BUY	$27.03 - $38.62 $12,568 - $17,958	465 Added 38.94%	1,659 $54,000
Q4 2019 Feb 14, 2020	BUY	$32.92 - $37.36 $39,306 - $44,607	1,194 New	1,194 $47,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Core Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Core Wealth Advisors, Inc. with notifications on news.